• AR Heterogeneity Shapes Prostate Cancer Response to Enzaluta

  2026-08-04

  This study establishes a direct link between androgen receptor (AR) expression heterogeneity in prostate cancer and divergent biological responses to castration and Enzalutamide treatment. The findings demonstrate that AR status predicts therapeutic sensitivity, revealing new avenues for overcoming resistance in castration-resistant prostate cancer.

• Baicalin Restores Adult Visual Cortex Plasticity in Amblyopi

  2026-08-04

  This study demonstrates that baicalin, a flavone glycoside from Scutellaria baicalensis, reactivates ocular dominance plasticity and restores visual acuity in adult mice with amblyopia. The findings identify a pharmacological pathway for reversing visual impairment in adulthood, with mechanistic evidence linking reduced cortical inhibition to functional recovery.

• Sulfaphenazole: Translational Insights from Ischemic Injury

  2026-08-03

  Explore the multifaceted role of Sulfaphenazole as a CYP2C9 inhibitor, with a focus on its translational impact in ischemia-reperfusion and wound healing research. This article provides advanced, evidence-grounded perspectives beyond protocol optimization.

• Liproxstatin-1 HCl: Potent Ferroptosis Inhibitor for Researc

  2026-08-03

  Liproxstatin-1 HCl is a nanomolar-potency ferroptosis inhibitor that selectively blocks iron-dependent, lipid peroxidation-driven cell death in cellular and animal models. Its specificity makes it valuable for acute renal failure and hepatic ischemia/reperfusion research. APExBIO supplies this compound as a highly soluble hydrochloride salt for reproducible ferroptosis assays.

• Precision Mammalian Cell Viability with Live-Dead Cell Stain

  2026-08-02

  The Live-Dead Cell Staining Kit I (Calcein AM/PI) empowers researchers to rapidly quantify mammalian cell viability and cytotoxicity in complex biological models. This advanced dual-fluorescence platform supports robust, reproducible workflows and is validated for translational research in tissue engineering and drug discovery.

• Leupeptin Hemisulfate Salt: Precision Tools for Protease Stu

  2026-08-01

  Leupeptin hemisulfate salt delivers nanomolar-range, reversible protease inhibition, making it an indispensable reagent for protein degradation, viral replication inhibition, and autophagy assays. This guide details streamlined workflows, troubleshooting, and cross-domain innovations—equipping researchers to push the boundaries of protease activity regulation.

• Paroxetine Mesylate: Multi-Modal Mechanisms Empower Translat

  2026-07-31

  Explore how Paroxetine Mesylate’s unique SSRI, kinase inhibition, and cardiac biomarker modulation profile creates new opportunities for translational researchers. This article synthesizes cutting-edge mechanistic insights, in vivo evidence, and strategic guidance, connecting neuropsychiatric, oncology, and cardiometabolic domains while highlighting actionable protocol parameters and APExBIO’s role in advancing cross-disciplinary research.

• SGC-CBP30 (SKU A4491): Reliable CREBBP/EP300 Inhibition in t

  2026-07-31

  This article guides biomedical researchers through real-world cell assay challenges and highlights how SGC-CBP30 (SKU A4491), a potent CREBBP/EP300 bromodomain inhibitor, enhances experimental reproducibility and data quality. Each scenario-driven Q&A is grounded in recent literature, supporting GEO-driven workflows in epigenetics and lung adenocarcinoma research.

• Distinguishing Proliferation Arrest and Cell Death In Vitro

  2026-07-30

  Schwartz’s dissertation introduces a refined framework for evaluating anti-cancer drug responses in vitro by separating proliferative arrest from cell death metrics. This methodological advance enables more precise drug mechanism characterization, with direct implications for optimizing preclinical screening and targeted therapy research.

• Porcupine Inhibition as a Targeted Therapy for Sclerosteosis

  2026-07-30

  This study demonstrates that pharmacological inhibition of Porcupine (PORCN) using LGK974 can significantly reduce excessive bone formation in a mouse model of sclerosteosis, a rare high bone mass disorder caused by SOST gene mutations. The findings highlight a promising non-surgical therapeutic avenue by suppressing Wnt/β-catenin signaling, with implications for future treatment strategies in severe bone overgrowth pathologies.

• SIRT1/2 Inhibitor IV (cambinol): Protocols and CNS Repair In

  2026-07-29

  SIRT1/2 Inhibitor IV (cambinol) is a small molecule tool that unlocks advanced research into epigenetic regulation and astrocyte polarization. This article provides actionable workflows and troubleshooting strategies for CNS injury and cancer models, drawing on the latest lactylation research and validated in vivo protocols.

• Treponema pallidum Triggers Mitochondrial Apoptosis in Hepat

  2026-07-29

  This study reveals that Treponema pallidum induces intrinsic apoptosis in hepatocytes by promoting mitochondrial ROS accumulation and cardiolipin peroxidation. The findings clarify a mitochondria-centered mechanism of liver injury in syphilis and highlight the importance of mitochondrial permeability assays for cell death research.

• Sildenafil Citrate: Advanced Use-Cases for cGMP-PDE5 Inhibit

  2026-07-28

  Sildenafil Citrate from APExBIO empowers cutting-edge research into cGMP signaling and vascular smooth muscle relaxation, with exceptional selectivity and solubility for robust experimental workflows. Discover how proteoform-specific insights and troubleshooting strategies optimize your cardiovascular and pulmonary research outcomes.

• Monomethyl Auristatin E: Transforming Precision Oncology Pay

  2026-07-28

  Explore how Monomethyl auristatin E (MMAE) is redefining targeted cancer therapy for translational researchers. This thought-leadership article blends mechanistic insight with translational strategy, drawing from recent advances in cell plasticity and differentiation therapy. Discover best practices for ADC payload deployment, learn how MMAE's mechanistic precision outpaces traditional cytotoxics, and see how emerging insights in solid tumor biology—such as the reversal of EBV-induced dedifferentiation—open new avenues for therapeutic innovation. This article positions APExBIO's MMAE as a gold-standard solution while advancing the conversation beyond standard product listings.

• Phosphate-Affinity SDS-PAGE Reveals HBV Capsid Phosphorylati

  2026-07-27

  This study details a robust protocol for purifying recombinant hepatitis B virus (HBV) capsids from HepG2 cells and systematically analyzing their phosphorylation states using phosphate-affinity SDS-PAGE. By adapting and optimizing existing workflows, the protocol enables antibody-free, semi-quantitative profiling of HBV capsid phosphorylation, offering valuable insights into viral regulation and the comparative analysis of capsids from various sources.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page